Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan 16:15:1362881.
doi: 10.3389/fimmu.2024.1362881. eCollection 2024.

Editorial: Regulation of tumor-immune microenvironment by non-coding RNAs

Rajeev Nema  1 , Rohit Saluja  2 , Ashok Kumar  3
Affiliations
Editorial

Editorial: Regulation of tumor-immune microenvironment by non-coding RNAs

Rajeev Nema et al. Front Immunol. .
No abstract available

Keywords: circular RNA (circRNA); exosomes; long non coding RNA; noncoding RNA; tumor micro environment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Various LncRNAs regulate the differentiation of naïve T cells into different subsets under homeostasis and during carcinogenesis. These subsets exhibit unique landscape of lncRNAs, which also control the trafficking of T cell subsets into tumor microenvironment (TME). Exosomal circular RNAs released by cancer cells and stromal cells orchestrate the TME.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Regulation of tumor-immune microenvironment by non-coding RNAs

References

    1. Anderson NM, Simon MC. The tumor microenvironment. Curr Biol (2020) 30:R921–5. doi: 10.1016/j.cub.2020.06.081 - DOI - PMC - PubMed
    1. Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics — challenges and potential solutions. Nat Rev Drug Discovery (2021) 20:629–51. doi: 10.1038/s41573-021-00219-z - DOI - PMC - PubMed
    1. Zagozdzon R, Winiarska M, Firczuk M. Immune evasion as the main challenge for immunotherapy of cancer. Cancers (2022) 14:3622. doi: 10.3390/cancers14153622 - DOI - PMC - PubMed

Publication types